• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    8/15/22 11:36:10 AM ET
    $API
    $BFRI
    $DNAA
    $EAST
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $API alert in real time by email

     

    On Monday, 31 companies hit new 52-week lows.

    Noteworthy Mentions In Today's 52-Week Lows:

    • The largest company in terms of market cap to set a new 52-week low was PetroChina Co (NYSE:PTR).
    • SciSparc (NASDAQ:SPRC) is the smallest company on a market cap basis to set a new 52-week low.
    • Nocera (NASDAQ:NCRA)'s stock dropped the most, trading down 15.92% to reach a new 52-week low.
    • Orion Energy Sys (NASDAQ:OESX)'s shares had the biggest turnaround, impressively rebounding 0.3% after reaching a new 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • GSK (NYSE:GSK) shares were down 4.07% for the day, having made a 52-week low of $34.43.
    • TTEC Holdings (NASDAQ:TTEC) shares set a new yearly low of $57.66 this morning. The stock was up 0.51% on the session.
    • SmartRent (NYSE:SMRT) shares were down 11.78% for the day, having made a 52-week low of $3.35.
    • Maverix Metals (AMEX:MMX) stock drifted down 3.79% on Monday morning to hit a new 52-week low of $3.80.
    • Agora (NASDAQ:API) shares hit a yearly low of $4.60. The stock was down 1.48% on the session.
    • Starry Group Holdings (NYSE:STRY) shares were down 2.58% for the day, having made a 52-week low of $2.66.
    • HomeTrust Bancshares (NASDAQ:HTBI) shares were down 0.89% for the day, having made a 52-week low of $22.86.
    • Social Cap Suvretta Hldgs (NASDAQ:DNAA) stock achieved a new 52-week low on Monday morning, hitting $9.48 and moving down 3.21%.
    • CorpHousing Group (NASDAQ:CHG) stock broke to a new 52-week low of $2.88 on Monday. Shares of the company traded down 14.05%.
    • Wag Group (NASDAQ:PET) shares moved down 4.78% on Monday to hit a new 52-week low of $7.12, drifting down 4.78%.
    • Inspirato (NASDAQ:ISPO) stock drifted down 6.17% on Monday morning to hit a new 52-week low of $3.68.
    • POET Technologies (NASDAQ:POET) stock hit a new 52-week low of $3.03. The stock was down 9.96% on the session.
    • Sierra Metals (AMEX:SMTS) stock set a new 52-week low of $0.51 on Monday, moving down 8.5%.
    • Forza X1 (NASDAQ:FRZA) shares set a new yearly low of $5.81 this morning. The stock was down 11.35% on the session.
    • Loyalty Ventures (NASDAQ:LYLT) stock broke to a new 52-week low of $2.56 on Monday. Shares of the company traded down 6.5%.
    • Orion Energy Sys (NASDAQ:OESX) shares fell to $1.63 on Monday, setting a new 52-week low with a shift of down 0.3%.
    • PLx Pharma (NASDAQ:PLXP) shares moved down 15.43% on Monday to hit a new 52-week low of $1.33, drifting down 15.43%.
    • IN8bio (NASDAQ:INAB) stock set a new 52-week low of $1.84 on Monday, moving up 1.62%.
    • Biofrontera (NASDAQ:BFRI) stock hit a new 52-week low of $1.30. The stock was down 6.38% on the session.
    • Nocera (NASDAQ:NCRA) stock set a new 52-week low of $2.00 on Monday, moving down 15.92%.
    • Eastside Distilling (NASDAQ:EAST) shares hit a yearly low of $0.52. The stock was down 12.46% on the session.
    • SciSparc (NASDAQ:SPRC) shares fell to $1.02 on Monday, setting a new 52-week low with a shift of down 6.24%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $API alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $API
    $BFRI
    $DNAA
    $EAST

    CompanyDatePrice TargetRatingAnalyst
    GSK plc
    $GSK
    1/27/2026Neutral
    Citigroup
    GSK plc
    $GSK
    1/6/2026Equal Weight → Underweight
    Barclays
    GSK plc
    $GSK
    11/25/2025Underperform → Neutral
    BofA Securities
    TTEC Holdings Inc.
    $TTEC
    11/10/2025Outperform → Mkt Perform
    William Blair
    GSK plc
    $GSK
    6/3/2025Buy → Hold
    Berenberg
    GSK plc
    $GSK
    4/15/2025$35.25Neutral
    Exane BNP Paribas
    GSK plc
    $GSK
    2/12/2025Equal-Weight
    Morgan Stanley
    Agora Inc.
    $API
    1/16/2025$6.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $API
    $BFRI
    $DNAA
    $EAST
    SEC Filings

    View All

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/10/26 7:52:50 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/9/26 11:57:42 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Biofrontera Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Biofrontera Inc. (0001858685) (Filer)

    3/9/26 9:20:28 AM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Holtzman Marc bought $186,215 worth of shares (73,056 units at $2.55), increasing direct ownership by 43% to 241,770 units (SEC Form 4)

    4 - TTEC Holdings, Inc. (0001013880) (Issuer)

    3/9/26 6:53:38 PM ET
    $TTEC
    Professional Services
    Consumer Discretionary

    SEC Form 4 filed by Director Weber Kevin Daniel

    4 - Biofrontera Inc. (0001858685) (Issuer)

    3/6/26 9:33:07 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO & Chairman Luebbert Hermann converted options into 137,500 shares, increasing direct ownership by 90% to 290,211 units (SEC Form 4)

    4 - Biofrontera Inc. (0001858685) (Issuer)

    3/6/26 9:31:43 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails

    TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, in which SciSparc holds a controlling interest of approximately 75%, has entered into a definitive share purchase agreement (the "SPA"), between NeuroThera, CliniQuantum Ltd. ("CliniQ") and the Selling Shareholders (as defined below) to acquire approximately 54.01% of the issued and outstanding ordinary shares of CliniQ (the "CliniQ Shares") on a fully diluted basis immediately prior to the closing

    3/10/26 9:28:00 AM ET
    $SPRC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TTEC Takes Home Seven Stevie® Awards for Pioneering AI-Driven Customer Experience and Sales Excellence

    AUSTIN, Texas, March 10, 2026 (GLOBE NEWSWIRE) -- TTEC, a leading global consulting, technology, and managed services company delivering solutions at the intersection of data, AI, and customer experience (CX), has won multiple honors in the prestigious Stevie® Awards for Sales & Customer Service. The company received three Gold, one Silver, and three Bronze awards recognizing innovation in AI-enabled training, advanced hiring, complex enterprise sales, and global CX delivery. Gold Awards Learning Wizard Suite earned Gold for Customer Service or Call Center Training Practice of the Year. This AI-powered learning platform accelerates associate readiness, reduces time to proficiency, and st

    3/10/26 9:23:50 AM ET
    $TTEC
    Professional Services
    Consumer Discretionary

    Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

    Innovative non-hallucinogenic treatment combines MEAI with Palmitoylethanolamide to address obesity and metabolic dysfunction-associated steatotic liver disease, tapping into a rapidly growing market projected to exceed $200 billion by 2035 Vancouver, Canada, March 10, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation,  neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the publication of an international patent application under the Patent Cooperation Treaty (PCT)

    3/10/26 8:59:00 AM ET
    $CMND
    $SPRC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Holtzman Marc bought $186,215 worth of shares (73,056 units at $2.55), increasing direct ownership by 43% to 241,770 units (SEC Form 4)

    4 - TTEC Holdings, Inc. (0001013880) (Issuer)

    3/9/26 6:53:38 PM ET
    $TTEC
    Professional Services
    Consumer Discretionary

    Director Holtzman Marc bought $234,040 worth of shares (100,000 units at $2.34), increasing direct ownership by 146% to 168,714 units (SEC Form 4)

    4 - TTEC Holdings, Inc. (0001013880) (Issuer)

    3/4/26 6:09:45 PM ET
    $TTEC
    Professional Services
    Consumer Discretionary

    EVP, CFO, CAO & Treasurer Brodin J Per bought $5,535 worth of shares (500 units at $11.07), increasing direct ownership by 0.54% to 92,811 units (SEC Form 4)

    4 - ORION ENERGY SYSTEMS, INC. (0001409375) (Issuer)

    2/27/26 6:19:11 PM ET
    $OESX
    Building Products
    Consumer Discretionary

    $API
    $BFRI
    $DNAA
    $EAST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on GlaxoSmithKline

    Citigroup initiated coverage of GlaxoSmithKline with a rating of Neutral

    1/27/26 8:46:26 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GlaxoSmithKline downgraded by Barclays

    Barclays downgraded GlaxoSmithKline from Equal Weight to Underweight

    1/6/26 11:51:57 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GlaxoSmithKline upgraded by BofA Securities

    BofA Securities upgraded GlaxoSmithKline from Underperform to Neutral

    11/25/25 8:32:06 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/14/24 3:54:03 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/14/24 1:13:39 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/13/24 2:12:35 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Financials

    Live finance-specific insights

    View All

    Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026

    WOBURN, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), announces it will report financial results for the three months and full year ended December 31, 2025 after the close of the U.S. financial markets on Thursday, March 19, 2026. The Company will host a conference call on Thursday, March 19, 2026 at 10:00 a.m. Eastern Time to discuss those results, provide a business update and answer questions. Conference Call and Webcast Information Event:Biofrontera Inc. Fourth Quarter and Full Year 2025 Financial Results and Busi

    3/9/26 5:25:00 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SmartRent Reports Fourth Quarter and Full-Year 2025 Financial Results

    Company Delivers Fourth Quarter 2025 Year-Over-Year Revenue Growth, Positive Adjusted EBITDA, and Maintains Strong Liquidity SmartRent, Inc. (NYSE:SMRT) ("SmartRent" or the "Company"), a leading provider of smart communities and operations solutions for the rental housing industry, today reported financial results for the three and twelve months ended December 31, 2025. Fourth Quarter 2025 Highlights; Total Revenue of $36.5 million, up 3% from prior year. Annual Recurring Revenue ("ARR") increased by 13% year over year to $61.6 million, now representing 42% of total revenue. Net loss aggregated $3.2 million compared with $11.4 million in the same quarter prior year. Improvement

    3/4/26 8:00:00 AM ET
    $SMRT
    EDP Services
    Technology

    Agora, Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    SANTA CLARA, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ:API) (the "Company"), a pioneer and leader in conversational AI and real-time engagement technology, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. "We are pleased to report our fifth consecutive quarter of GAAP profitability, marking our first full year of profitability since 2018, driven by sustained double-digit revenue growth," said Tony Zhao, Founder, Chairman, and CEO of Agora, Inc. "Our platform's scalability was validated during a high-profile Super Bowl live shopping event, where we streamed full HD video to nearly 600,000 peak concurrent

    3/2/26 5:00:00 PM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    $API
    $BFRI
    $DNAA
    $EAST
    Leadership Updates

    Live Leadership Updates

    View All

    Appia Announces Appointment of VP Corporate Development

    Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Appia Rare Earths & Uranium Corp. (CSE:API) (OTCQB:APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) (the "Company" or "Appia") is pleased to announce that Jason Bagg has been appointed Vice-President Corporate Development, effective January 15, 2026. Mr. Bagg brings over 25 years of financial and uranium sector experience, including his position as Chief Executive Officer of Urano Energy Corp, and Puranium Energy Ltd. Tom Drivas, CEO of Appia, commented:"On behalf of the Board of Directors, it is my pleasure to welcome Jason to the Appia team. His experience in the financial markets and the uranium sector comes at a pivotal time as the Compa

    1/15/26 7:30:00 AM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    Melissa Xides Appointed Exclusive Resorts President

    Former Bergdorf Goodman executive joins to strengthen a more private, relationship-led Club for a discerning global Membership Exclusive Resorts today announced the appointment of Melissa Xides as President, signaling a new chapter for the Members-only luxury club following a sustained period of growth and the recent launch of The Exclusive Collective, uniting three market-leading brands to form one of the most expansive private networks in luxury hospitality. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113869302/en/Melissa Xides, President - Exclusive Resorts After more than six years of expansion across the Club's $1 b

    1/13/26 8:00:00 AM ET
    $ISPO
    Blank Checks
    Finance

    SmartRent Names Sangeeth Ponathil Chief Information Officer

    Proven technology leader to drive the Company's technology strategy SmartRent, Inc. (NYSE:SMRT) ("SmartRent" or the "Company"), a leading provider of smart communities and smart operations solutions for the rental housing industry, today announced the appointment of Sangeeth Ponathil as Chief Information Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117547781/en/A proven executive leader with more than 25 years of experience guiding enterprise technology strategy, Sangeeth Ponathil will chart SmartRent's technology roadmap moving forward. His acumen in corporate digital transformation, infrastructure modernization

    11/17/25 4:15:00 PM ET
    $SMRT
    EDP Services
    Technology